Results 21 to 30 of about 758,852 (295)

Cutaneous leishmaniasis mimicking cutaneous lymphoma

open access: yesIDCases, 2019
Cutaneous leishmaniasis (CL) is caused by protozoa of Leishmania genus that are transmitted to humans through the bite of sand flies (Lutzomyia and Phlebotomus). The infection is classically manifested as multiple or single ulcers affecting cutaneous and/or mucosal areas of the body.
Carla Andréa Avelar Pires   +9 more
openaire   +3 more sources

A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset. [PDF]

open access: yes, 2012
OBJECTIVE: A prospective observational study of mycophenolate mofetil (MMF) treatment in patients with diffuse progressive cutaneous systemic sclerosis (SSc) of recent onset.
Jimenez, Sergio A.   +3 more
core   +3 more sources

Single-cell analysis reveals differences among iNKT cells colonizing peripheral organs and identifies Klf2 as a key gene for iNKT emigration

open access: yesCell Discovery, 2022
Invariant natural killer T cell (iNKT) subsets are differentially distributed in various immune organs. However, it remains unclear whether iNKT cells exhibit phenotypical and functional differences in different peripheral organs and how thymic iNKT ...
Jie Wang   +9 more
doaj   +1 more source

Retrospective study of more than 9000 feline cutaneous tumours in the UK: 2006–2013 [PDF]

open access: yes, 2017
The aim of the study was to utilise a large database available from a UK-based, commercial veterinary diagnostic laboratory to ascertain the prevalence of different forms of cutaneous neoplasia within the feline population, and to detect any breed, sex ...
Dobromylskyj, M J, Ho, N T, Smith, K C
core   +2 more sources

Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature

open access: yesDermatology and Therapy, 2019
Folliculotropic mycosis fungoides (FMF) is an aggressive variant of mycosis fungoides (MF) characterized by infiltration of the hair follicle epithelium by neoplastic T cells.
Doaa Shalabi   +2 more
doaj   +1 more source

The αMSH-Dependent PI3K Pathway Supports Energy Metabolism, via Glucose Uptake, in Melanoma Cells

open access: yesCells, 2023
Stimulation of melanocytes and murine melanoma cells with αMSH plus the PI3K inhibitor LY294002 resulted in ROS increase, oxidative DNA damage, and pigment retention.
Giorgia Cardinali   +7 more
doaj   +1 more source

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

open access: yesMelanoma Management, 2019
Aim: To assess the impact of re-biopsy on partially sampled melanoma in situ (MIS), atypical melanocytic proliferation (AMP) and thin invasive melanoma.
Evan S Weitman   +10 more
doaj   +1 more source

Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review

open access: yesJournal of Dermatological Treatment, 2023
Seborrheic keratoses (SKs) are benign epidermal neoplasms presenting as waxy, brown to black papules and plaques. Patients often seek removal for cosmetic reasons or irritation. The objective of this systematic review is to assess the efficacy and safety
Nicole Natarelli   +4 more
doaj   +1 more source

De novo head and neck cancer after liver transplant with antibody-based immunosuppression induction [PDF]

open access: yes, 2018
Background Powerful antibody-based immunosuppression induction is now used routinely during organ transplantation, and may place patients at even higher risk of post-transplant cancer.
Graham, Ryan C.   +2 more
core   +1 more source

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. [PDF]

open access: yes, 2014
BackgroundCanine cutaneous T-cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC-1101 (formerly known as GS-9219) has shown efficacy in dogs with multicentric lymphoma.
Burgess, KE   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy